HOME >> BIOLOGY >> NEWS
Light to moderate drinking during pregnancy can affect adolescent growth

  • Children with Fetal Alcohol Syndrome (FAS) commonly have growth deficits.
  • Growth deficits also exist among children prenatally exposed to alcohol but without FAS.
  • Researchers have found significant growth deficits among non-FAS children 14 years after birth.
  • The deficits have a dose-response relation to gestational exposure, and are evident at consumption levels less than one drink per day.

Growth deficits are common among children with Fetal Alcohol Syndrome (FAS), affecting their height, weight, and head circumference. Growth deficits have also been found among offspring exposed to alcohol during gestation but who have not developed FAS. Studies have, however, differed in this finding. Furthermore, few studies have followed offspring who were prenatally exposed to alcohol beyond their early and middle childhoods. A study in the October issue of Alcoholism: Clinical & Experimental Research examines the effects of alcohol exposure during gestation on the size of non-FAS offspring at 14 years of age.

"The Maternal Health Practices and Child Development Project began in 1982," said Nancy L. Day, professor of psychiatry and epidemiology at the University of Pittsburgh School of Medicine and lead author of the study. "Its purpose has been to study the effects of prenatal exposure to alcohol, marijuana, tobacco, and other illicit drugs on the growth and development of the offspring. At numerous intervals, we have measured demographic status, the psychological, social, and household environment, maternal and paternal substance use, and substance use of the male partner in the household. We have also assessed the children's cognitive, behavioral, academic, and physical status. Furthermore, at ages 10, 14, and 16, we have additional measures of the children's pubertal maturity, neuropsychological status, cognitive and behavioral development, affect, academic performance, psychiatric status, delinquent behavio
'"/>


15-Oct-2002


Page: 1 2 3 4

Related biology news :

1. Light turns on anticancer agents
2. Light Biology, a biotech company based on UT Southwestern technology, bought by NimbleGen Systems
3. Shedding Light on Disease: A Briefing for Journalists
4. Light at the end of the tunnel: Photonics are tipped to make global communications network a reality
5. Light shed on vision and hearing disorders
6. Brookhaven Spotlights: News from the National Synchrotron Light Source
7. Light receptor may be key in how animals use Earths magnetic field
8. Studies Of A Gene For A Rare Form Of Rickets Shed Light On Vitamin D Deficiencies
9. New Study By TSRI Scientists Sheds Light On Viral Clearance In Acute Hepatitis B Infection
10. Fake Photosynthesis? Test-Tube System In Science Paper Sheds Light On The Oxygen We Breathe, UD Prof Says
11. Sunscreen Ingredient Causes DNA Damage In Light

Post Your Comments:
(Date:7/8/2015)... July 8, 2015 Summary Pancreatic cancer ... fourth most fatal, with a mortality rate of 10.9 ... of pancreatic cancer patients has highlighted a significant need ... not being met by the current market. A ... products with varying molecule types and mechanisms of action, ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:6/30/2015)... YORK , June 30, 2015 To bolster ... security provider HYPR Corp. announced today the addition of two ... will serve as board advisor and David Raviv ... the team underscore HYPR Corp.,s commitment to providing the most ... Dimitri Sirota co-founded Layer 7 Technologies, a provider ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
(Date:7/29/2015)... Station, TX (PRWEB) , ... July 29, 2015 ... ... POD® designer, manufacturer and supplier, announces the launch of their 2nd generation cell ... to the current miniPOD CT, but it also represents a new POD® design. ...
(Date:7/29/2015)... 29, 2015  AmnioChor Inc., an early stage biotech ... pleased to announce that the Musculoskeletal Transplant Foundation of ... invest in their seed round of development of the ... capabilities. AmnioChor,s technology allows cryopreservation of ... stem cells living within those tissues. Amnion is a ...
(Date:7/29/2015)...  Indivior PLC (LON: INDV) today announced that the ... accepted and received Priority Review by the U.S. Food ... overdose. This naloxone nasal spray comes as a pre-filled ... into the nasal mucosa. 1 The device has ... be better equipped to help an opioid overdose victim. ...
(Date:7/29/2015)... QUEBEC CITY , July 29, 2015 /PRNewswire/ ... (the "Company") today announced it has selected an optimized ... important milestone in the development of a new ... The MAPK pathway represents a prime target for ... significant antitumor activities and survival benefits for B-Raf ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: